bioenergetics in human epilepsy - uk healthcare … · path to bioenergetics in epilepsy •...
TRANSCRIPT
Bioenergetics in Human Epilepsy: Relevance for Etiology, Mechanisms, and Management
Frank Gilliam, MD, MPH Professor of Neurology University of Kentucky
Path to Bioenergetics in Epilepsy
• Genomics of Human Epilepsy Surgery Tissue • Preliminary Findings in Cortical Dysplasias • Intracellular Bioenergitics and Hyerexcitability • Search for Pharmacological Treatment • Possible Role for Metformin
“Finally, two genes are unique to HHV-6 … U83 encodes a chemokine with chemotactic activity for monocytic cells, and is expressed in two forms. The spliced variant is expressed as an early protein, before DNA replication, and the full length protein is expressed only after DNA replication (Dewin et al., 2006).”
• HPV 16 E6 robustly expressed in 50 epilepsy brains with balloon cells.
• Not expressed in 20 normal control samples
Ann Neurol. 72:881-92, 2012.
Mammalian target of rapamycin (mTOR) pathways in neurological diseases
Wong, M. Biomed. J. 36:40-50, 2013
Neuropace RNS Effect after Optimal Programming: Double Cortex Syndrome
Typical Electrographic seizure now: No clinical effect
Typical initial seizure prior to RNS optimization: Staring and decrease responsiveness